Our results revealed significantly lower expression of both CYR61 and CTGF in human cervical cancer samples as compared with their normal counterparts (P = 0.002 and P<0.001, respectively; Figure 3A–C). The gene discussed is CCN2; the disease is cervical carcinoma.